AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Improving Progression-free Survival with Peptide Receptor Radionuclide Therapy
Exploring the benefits of 177 ludotate in treating mid-gut neuroendocrine tumors, showcasing improved progression-free survival rates compared to octreotide LAR, and highlighting potential solutions for Vipomas.